Header Logo

Connection

Michael Heneka to Neurodegenerative Diseases

Back to Details
This is a "connection" page, showing publications Michael Heneka has written about Neurodegenerative Diseases.
Michael Heneka
Connection Strength
7.561
Neurodegenerative Diseases
  1. Castro-Gomez S, Heneka MT. Innate immune activation in neurodegenerative diseases. Immunity. 2024 04 09; 57(4):790-814.
    View in: PubMed
    Score: 0.709
  2. Budinger D, Baker V, Heneka MT. Tunneling Nanotubes in the Brain. Results Probl Cell Differ. 2024; 73:203-227.
    View in: PubMed
    Score: 0.696
  3. Dadwal S, Heneka MT. Microglia heterogeneity in health and disease. FEBS Open Bio. 2024 02; 14(2):217-229.
    View in: PubMed
    Score: 0.690
  4. Ravichandran KA, Heneka MT. Inflammasome activation in neurodegenerative diseases. Essays Biochem. 2021 12 22; 65(7):885-904.
    View in: PubMed
    Score: 0.605
  5. Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020 06 04; 12(1):69.
    View in: PubMed
    Score: 0.543
  6. Scheiblich H, Trombly M, Ramirez A, Heneka MT. Neuroimmune Connections in Aging and Neurodegenerative Diseases. Trends Immunol. 2020 04; 41(4):300-312.
    View in: PubMed
    Score: 0.534
  7. Heneka MT. Microglia take centre stage in neurodegenerative disease. Nat Rev Immunol. 2019 02; 19(2):79-80.
    View in: PubMed
    Score: 0.495
  8. Tejera D, Heneka MT. Microglia in Neurodegenerative Disorders. Methods Mol Biol. 2019; 2034:57-67.
    View in: PubMed
    Score: 0.492
  9. Heneka MT, McManus RM, Latz E. Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci. 2018 10; 19(10):610-621.
    View in: PubMed
    Score: 0.484
  10. Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014 Jul; 14(7):463-77.
    View in: PubMed
    Score: 0.360
  11. Heneka MT, Rodr?guez JJ, Verkhratsky A. Neuroglia in neurodegeneration. Brain Res Rev. 2010 May; 63(1-2):189-211.
    View in: PubMed
    Score: 0.262
  12. Heneka MT, Landreth GE. PPARs in the brain. Biochim Biophys Acta. 2007 Aug; 1771(8):1031-45.
    View in: PubMed
    Score: 0.220
  13. Sabbagh MN, Cummings JL, Ballard C, van der Flier WM, Heneka MT, Holst JJ, Knudsen LB, Salloway S, Tansey MG, Drucker DJ. Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders. Nat Aging. 2026 Jan; 6(1):56-67.
    View in: PubMed
    Score: 0.199
  14. Vear A, Heneka MT, Clemmensen C. Incretin-based therapeutics for the treatment of neurodegenerative diseases. Nat Metab. 2025 Apr; 7(4):679-696.
    View in: PubMed
    Score: 0.190
  15. Bonhenry D, Charnley M, Gon?alves J, Hammarstr?m P, Heneka MT, Itzhaki R, Lambert JC, Mannan M, Baig AM, Middeldorp J, Nystr?m S, Reynolds NP, Stefanatou M, Berryman JT. SARS-CoV-2 infection as a cause of neurodegeneration. Lancet Neurol. 2024 06; 23(6):562-563.
    View in: PubMed
    Score: 0.179
  16. Talavera And?jar B, Mary A, Venegas C, Cheng T, Zaslavsky L, Bolton EE, Heneka MT, Schymanski EL. Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer's Disease Patients? Environ Sci Technol. 2024 Mar 05; 58(9):4181-4192.
    View in: PubMed
    Score: 0.176
  17. Brosseron F, Kleemann K, Kolbe CC, Santarelli F, Castro-Gomez S, Tacik P, Latz E, Jessen F, Heneka MT. Interrelations of Alzheimer?s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammation. J Neurochem. 2021 06; 157(6):2210-2224.
    View in: PubMed
    Score: 0.139
  18. Ising C, Heneka MT. Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration. Cell Death Dis. 2018 01 25; 9(2):120.
    View in: PubMed
    Score: 0.115
  19. Labzin LI, Heneka MT, Latz E. Innate Immunity and Neurodegeneration. Annu Rev Med. 2018 01 29; 69:437-449.
    View in: PubMed
    Score: 0.114
  20. Sarlus H, Heneka MT. Microglia in Alzheimer's disease. J Clin Invest. 2017 Sep 01; 127(9):3240-3249.
    View in: PubMed
    Score: 0.112
  21. Kleinberger G, Yamanishi Y, Su?rez-Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger-Weinzierl A, Mazaheri F, Tahirovic S, Lle? A, Alcolea D, Fortea J, Willem M, Lammich S, Molinuevo JL, S?nchez-Valle R, Antonell A, Ramirez A, Heneka MT, Sleegers K, van der Zee J, Martin JJ, Engelborghs S, Demirtas-Tatlidede A, Zetterberg H, Van Broeckhoven C, Gurvit H, Wyss-Coray T, Hardy J, Colonna M, Haass C. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014 Jul 02; 6(243):243ra86.
    View in: PubMed
    Score: 0.090
  22. Rey NL, Jardanhazi-Kurutz D, Terwel D, Kummer MP, Jourdan F, Didier A, Heneka MT. Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice. Neurobiol Aging. 2012 Feb; 33(2):426.e1-11.
    View in: PubMed
    Score: 0.070
  23. Galea E, Heneka MT, Dello Russo C, Feinstein DL. Intrinsic regulation of brain inflammatory responses. Cell Mol Neurobiol. 2003 Oct; 23(4-5):625-35.
    View in: PubMed
    Score: 0.043
  24. Bartsch T, Berg D, Heneka M, Leypoldt F. [Parkinson's and Alzheimer's disease as system-wide neurodegenerative disorders]. Nervenarzt. 2023 Oct; 94(10):875-884.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.